Thanks very much.
Even before we get to post-market, I was interested in what the FDA had, because I understood that in the case of drugs for which most of the research and approvals were done in other countries, such as the EU or Japan or other places, there'd be a committee of stakeholders that could fast-track a drug into the market, and then you would watch it in a post-market way. Is that true, or was that an experiment? How did that go?